Key Laboratory for Liquid-Solid Structural Evolution & Processing of Materials (Ministry of Education), School of Materials Science and Engineering, Shandong University, Jinan, Shandong, 250061, P. R. China.
School of Chemistry, University of New South Wales (UNSW), Sydney, NSW 2052, Australia.
Mater Horiz. 2024 Sep 16;11(18):4275-4310. doi: 10.1039/d4mh00470a.
Metal ion interference therapy (MIIT) has emerged as a promising approach in the field of nanomedicine for combatting cancer. With advancements in nanotechnology and tumor targeting-related strategies, sophisticated nanoplatforms have emerged to facilitate efficient MIIT in xenografted mouse models. However, the diverse range of metal ions and the intricacies of cellular metabolism have presented challenges in fully understanding this therapeutic approach, thereby impeding its progress. Thus, to address these issues, various amplification strategies focusing on ionic homeostasis and cancer cell metabolism have been devised to enhance MIIT efficacy. In this review, the remarkable progress in Fe, Cu, Ca, and Zn ion interference nanomedicines and understanding their intrinsic mechanism is summarized with particular emphasis on the types of amplification strategies employed to strengthen MIIT. The aim is to inspire an in-depth understanding of MIIT and provide guidance and ideas for the construction of more powerful nanoplatforms. Finally, the related challenges and prospects of this emerging treatment are discussed to pave the way for the next generation of cancer treatments and achieve the desired efficacy in patients.
金属离子干扰治疗(MIIT)已成为纳米医学领域中一种有前途的癌症治疗方法。随着纳米技术和肿瘤靶向相关策略的进步,出现了复杂的纳米平台,以促进异种移植小鼠模型中有效的 MIIT。然而,金属离子的多样性和细胞代谢的复杂性给全面理解这种治疗方法带来了挑战,从而阻碍了其发展。因此,为了解决这些问题,设计了各种聚焦于离子动态平衡和癌细胞代谢的放大策略来增强 MIIT 的疗效。在这篇综述中,总结了 Fe、Cu、Ca 和 Zn 离子干扰纳米药物方面的显著进展,并特别强调了用于增强 MIIT 的各种放大策略的类型,以深入了解 MIIT,并为构建更强大的纳米平台提供指导和思路。最后,讨论了这种新兴治疗方法的相关挑战和前景,为下一代癌症治疗铺平道路,并在患者中实现预期疗效。